ERBB2 and breast carcinoma: In this study, we downloaded the RNA-SEQ data of HER2-positive breast cancer and triple-negative breast cancer from the TCGA database, then identified and compared the differential metabolic genes in HER2-positive, triple-negative, and normal adjacent control tissues and analyzed the pathway enrichment.